Exacerbations of chronic obstructive pulmonary disease (COPD) 

SBIMC/BVIKM - NVMM - VIZ joint meeting: Antwerp, November 7-8th, 2002

Click here to start


Table of Contents

Infectious disease syndromes

COPD, the clinical problem

Leading cause of death as percentages of total deaths in 1980 and 1992

RTIs are one of the most common reasons for consulting a GP

One-year survival of patient with severe acute exacerbations of COPD

Cause of death in 200 COPD patients

PPT Slide

ARE ANTIMICROBIAL AGENTS USEFUL

PPT Slide

PLACEBO CONTROLLED STUDIES OF ANTIBIOTIC THERAPY IN AECB

PLACEBO CONTROLLED STUDIES OF ANTIBIOTIC THERAPY IN AECB

PPT Slide

PPT Slide

Outcome of exacerbations of COPD by Type

VIRAL AND ATYPICAL PATHOGENS IN Type-1 AECB

PPT Slide

Relative risk of an exacerbation according to whether a NEW STRAIN was isolated

Antibacterial therapy for AECB (5–10 days)

Penicilline resistentie S.pneumoniae

Proportions of PNSP in 2001

Erythromycine resistentie S.pneumoniae

PPT Slide

PPT Slide

Erythromycin-Resistant Streptococcus pneumoniae and Macrolide Consumption in EU Member States, 1997-1998

Beta-lactamase production in H.influenzae and M.catarrhalis

Recommendations by professional societies regarding the usage of antimicrobial agents for AE of COPD

SWAB richtlijn AECB in het ziekenhuis

Conclusions

Author: A.I. Hoepelman

Email: webmaster@sbimc-bvikm.org

Home Page: http://www.sbimc-bvikm.org/sbimc-bvikm-slides.htm

Other information:
These slides are for information only. Do not make public use of them without the autorization of their author and of the SBIMC-BVIKM.

Download presentation as PDF file